The advertisement promotes awareness about the importance of differential diagnosis between drug-induced parkinsonism (DIP) and tardive dyskinesia (TD), highlighting the relevance of accurate diagnosis in treatment.
Creative Information
| CID: | 96c04938-3034-43bf-92e7-e0ea0165ad38 |
| CRID: | 2_206_456716 |
| Domain: | tevapharm.com |
| Seat: | BSW |
| Size: | 320x50 |
| Bid: | $8.37 |
| Timestamp: | 11/18/2025, 9:52:34 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/19/2025, 12:58:57 AM | 4.86s | |
| adomain_analysis | success | 11/19/2025, 12:58:40 AM | 3.15s | |
| adomain_capture | success | 11/19/2025, 12:58:37 AM | 0.17s | |
| ad_render | success | 11/19/2025, 12:58:52 AM | 16.07s | |
| brand_mapping | success | 11/18/2025, 9:52:34 PM | 0.07s | |
Analysis Results
| Size: | 320x50 | ||||||||||||||||||||||
| Data Transferred: | 542.56 KB | ||||||||||||||||||||||
| Render Time: | 7.40 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 561.69 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<ins class='dcmads' style='display:inline-block;width:320px;height:50px' data-dcm-placement='N733.2055741ADTHEORANT/B32690683.410433783' data-dcm-rendering-mode='script' data-dcm-https-only data-dcm-keywords='02834b83-c024-11f0-ba1d-42010ab200bb' data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D456716%3BsId%3D737400%3BlId%3D91828%3BcId%3D17675%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3D02834b83-c024-11f0-ba1d-42010ab200bb%3BadThdId%3D4e8924bed5cfc31bed3247d773b3091e%3BengineId%3D8169948112780119524%3BdIp%3DNzUuMTg2LjEwOS43OQ%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D37286%3BinventoryId%3D264964%3BrtdmIndicator%3D1%3Btimestamp%3D1762992134%3Blat%3DMzkuNDI%3Blong%3DLTg0LjE5%3Bdma%3DNTE1%3BstateCode%3D%3Bzip%3DNDUxNTI%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D' data-dcm-resettable-device-id='' data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://rtb.adentifi.com/Imps?impId=1;adId=02834b83-c024-11f0-ba1d-42010ab200bb;lId=91828;sId=737400;cId=17675;crId=456716;adThdId=4e8924bed5cfc31bed3247d773b3091e;adExchange=BidSwitch;engineId=8169948112780119524;dealId=0;geoId=37286;inventoryId=264964;rtdmIndicator=1;timestamp=1762992134;property=mlbtraderumors.com;dIp=NzUuMTg2LjEwOS43OQ;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=4956403551672071465;hhId=271936873;cuid=cuid_87f057b1-1569-11f0-8c10-123a7eade4d1' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_87f057b1-1569-11f0-8c10-123a7eade4d1");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><img src='https://sb.scorecardresearch.com/p?c1=9&c2=16077523&c3=2&cs_xi=cuid_87f057b1-1569-11f0-8c10-123a7eade4d1&rn=02834b83-c024-11f0-ba1d-42010ab200bb' height='0' width='0' /><span id="te-clearads-js-adtheorent01cont456716"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=17675&c=adtheorent01cont456716&w=320&h=50&js=pmw0&plc=tr&uid=4e8924bed5cfc31bed3247d773b3091e"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=206&imp=1" alt=" " style="display:none"/>Creatives
